Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)
Open Access

Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy

Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe and Guido Böning
Journal of Nuclear Medicine January 2023, jnumed.122.264594; DOI: https://doi.org/10.2967/jnumed.122.264594
Julia Brosch-Lenz
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Astrid Delker
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friederike Völter
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena M Unterrainer
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Kaiser
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibylle Ziegler
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arman Rahmim
2 Department of Integrative Oncology, BC Cancer Research Institute, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Uribe
3 Department of Radiology, University of British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido Böning
1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.122.264594
DOI 
https://doi.org/10.2967/jnumed.122.264594
PubMed 
36657980

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online January 19, 2023.

Copyright & Usage 
Copyright © 2023 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Julia Brosch-Lenz1,
  2. Astrid Delker1,
  3. Friederike Völter1,
  4. Lena M Unterrainer1,
  5. Lena Kaiser1,
  6. Peter Bartenstein1,
  7. Sibylle Ziegler1,
  8. Arman Rahmim2,
  9. Carlos Uribe3 and
  10. Guido Böning1
  1. 1 Department of Nuclear Medicine, University Hospital, LMU Munich, Canada;
  2. 2 Department of Integrative Oncology, BC Cancer Research Institute, Canada;
  3. 3 Department of Radiology, University of British Columbia, Canada
  1. For correspondence or reprints contact: Julia Brosch-Lenz, BC Cancer Research Institute, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada. E-mail: jbrosch@bccrc.ca

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2023 to February 2023

AbstractFullPdf
Jan 202317800365
Feb 20237330221
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (3)
Journal of Nuclear Medicine
Vol. 64, Issue 3
March 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe, Guido Böning
Journal of Nuclear Medicine Jan 2023, jnumed.122.264594; DOI: 10.2967/jnumed.122.264594

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe, Guido Böning
Journal of Nuclear Medicine Jan 2023, jnumed.122.264594; DOI: 10.2967/jnumed.122.264594
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • PSMA PET/CT–based Atlas for Prostatic Bed Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines
  • PSMA-GCK01 - A Generator-Based 99mTc-/188Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
  • Radioimmunoscintigraphy and pre-treatment dosimetry of 131I-omburtamab for planning treatment of leptomeningeal disease
Show more Clinical Investigations (Human)

Clinical (Radiobiology/Dosimetry/Safety)

  • Biodistribution, Dosimetry, and Pharmacokinetics of 68Ga-CBP8: A type I collagen targeted PET probe
  • 64Cu Treatment Planning and 67Cu Therapy with Radiolabelled SARTATE ([64Cu/67Cu]MeCOSAR-Octreotate) in Subjects with Unresectable Multifocal Meningioma – Initial Results for Human Imaging, Safety, Biodistribution and Radiation Dosimetry
Show more Clinical (Radiobiology/Dosimetry/Safety)

Similar Articles

Keywords

  • Oncology: GU
  • Radiobiology/Dosimetry
  • radionuclide therapy
  • Lutetium-177
  • PSMA therapy
  • Single Time Point Dosimetry
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire